Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D D Callas

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Thrombosis Research|September 15, 1996
Comparative anticoagulant effects of various thrombin inhibitors, as determined in the ecarin clotting time methodD D Callas, J Fareed
Thrombosis Research|June 1, 1995
Direct inhibition of protein Ca by site directed thrombin inhibitors: implications in anticoagulant and thrombolytic therapyD D Callas, J Fareed
Thrombosis Research|July 1, 1996
Comparative studies on the antithrombin potency of various thrombin inhibitors, as determined by using an amidolytic methodD D Callas, J Fareed
Seminars in Thrombosis and Hemostasis|January 1, 1995
Comparative studies on the anticoagulant and protease generation inhibitory actions of newly developed site-directed thrombin inhibitory drugs. Efegatran, argatroban, hirulog, and hirudinD D Callas, D Hoppensteadt, J Fareed
Seminars in Thrombosis and Hemostasis|January 1, 1995
Studies on the thrombogenic effects of recombinant tissue factor. In vivo versus ex vivo findingsD D Callas, P Bacher, J Fareed
Thrombosis Research|February 15, 1993
Molecular weight and biochemical profile of a chemically modified heparin derivative, SuleparoideD D Callas, A Ahsan, O Iqbal, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 1, 1995
Tissue factor antigen levels in various biological fluidsJ Fareed, D D Callas, D Hoppensteadt, et al.
JAMA|August 11, 2000
Evidence of myocardial infarction in mummified human tissueR Miller, D D Callas, S E Kahn, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1993
Comparative pharmacologic profile of a glycosaminoglycan mixture, Sulodexide, and a chemically modified heparin derivative, SuleparoideD D Callas, D A Hoppensteadt, W Jeske, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 22, 2000
Antithrombin agents: the new class of anticoagulant and antithrombotic drugsJ Fareed, B E Lewis, D D Callas, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Thrombosis Research|September 15, 1996
Comparative anticoagulant effects of various thrombin inhibitors, as determined in the ecarin clotting time methodD D Callas, J Fareed
Thrombosis Research|June 1, 1995
Direct inhibition of protein Ca by site directed thrombin inhibitors: implications in anticoagulant and thrombolytic therapyD D Callas, J Fareed
Thrombosis Research|July 1, 1996
Comparative studies on the antithrombin potency of various thrombin inhibitors, as determined by using an amidolytic methodD D Callas, J Fareed
Seminars in Thrombosis and Hemostasis|January 1, 1995
Comparative studies on the anticoagulant and protease generation inhibitory actions of newly developed site-directed thrombin inhibitory drugs. Efegatran, argatroban, hirulog, and hirudinD D Callas, D Hoppensteadt, J Fareed
Seminars in Thrombosis and Hemostasis|January 1, 1995
Studies on the thrombogenic effects of recombinant tissue factor. In vivo versus ex vivo findingsD D Callas, P Bacher, J Fareed
Thrombosis Research|February 15, 1993
Molecular weight and biochemical profile of a chemically modified heparin derivative, SuleparoideD D Callas, A Ahsan, O Iqbal, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 1, 1995
Tissue factor antigen levels in various biological fluidsJ Fareed, D D Callas, D Hoppensteadt, et al.
JAMA|August 11, 2000
Evidence of myocardial infarction in mummified human tissueR Miller, D D Callas, S E Kahn, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1993
Comparative pharmacologic profile of a glycosaminoglycan mixture, Sulodexide, and a chemically modified heparin derivative, SuleparoideD D Callas, D A Hoppensteadt, W Jeske, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 22, 2000
Antithrombin agents: the new class of anticoagulant and antithrombotic drugsJ Fareed, B E Lewis, D D Callas, et al.
Pageof 2